BPC-157 + TB-500 10 mg + 10 mg

BPC-157 + TB-500 10 mg + 10 mg — the definitive repair-research pairing, at double strength.
BPC-157 and TB-500 are the two most-referenced compounds in regenerative peptide literature, and they are studied together because their mechanisms barely overlap. This 10 mg + 10 mg vial gives laboratories the headroom to run wider concentration ranges from a single batch.

What is this combination?

BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of body protection compound, a protein identified in gastric juice. It is notably stable in acidic conditions and is studied for angiogenic signalling, growth factor pathway interaction and cytoprotection. TB-500 is a synthetic peptide corresponding to the actin-binding region of thymosin beta-4, the principal actin-sequestering protein in mammalian cells; it is studied for cell migration, cytoskeletal reorganisation and vascular sprouting. The pairing is mechanistically complementary rather than redundant: one arm of the research concerns signalling and vascularisation, the other concerns the structural machinery cells use to move into a repair site.

Research interest

• Tissue repair models — investigated in preclinical systems examining connective and soft tissue recovery.
• Angiogenesis — both components appear in vascular network formation research through different routes.
• Cell migration and motility — the TB-500 component is a reference tool in actin dynamics studies.
• Growth factor pathway crosstalk — of interest to researchers examining upstream signalling in repair cascades.
• Comparative and additive design — a standard pairing for testing whether distinct mechanisms combine in repair models.

Specifications

• Content: 10 mg BPC-157 + 10 mg TB-500 per vial
• Form: Lyophilised powder (sealed vial)
• Purity: Pharmaceutical-grade, batch-tested
• Storage: 2–8 °C sealed and dry; −20 °C for long-term, protected from light

Handling & storage

Both Peptides are supplied lyophilised because the dry cake is dramatically more stable than solution. Keep the vial sealed, cold and dry until use, and equilibrate to room temperature before opening so that atmospheric moisture does not condense onto the powder. Reconstitute under the receiving laboratory's own validated protocol: introduce solvent slowly down the inner wall, let it run over the cake and swirl gently until clear. Avoid vortexing and any handling that generates foam. Use low-binding tubes and tips for aliquoting, hold aliquots frozen and protected from light, and thaw each once only — repeated freeze–thaw cycling is the most common source of avoidable variability.

Why source from Rogue

• Verified purity — batch-tested material with documented identity and assay results.
• European supply chain — factory-sealed vials held in controlled conditions, never repackaged or grey-market.
• Discreet, tracked delivery — rapid EU-wide dispatch in unbranded, protective outer packaging.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only.